文献速递产科母胎医学

妊娠期高血压疾病<33周引产与临产前剖宫产的结局比较

Outcomes of induction vs prelabor cesarean delivery at <33 weeks for hypertensive disorders of pregnancy.
PubMed 文献 · Am J Obstet Gynecol MFM · 2023-05-26

本研究为观察性研究的二次分析,纳入2008至2011年美国25家医院115502例患者中因妊娠期高血压疾病于230至<330周分娩的471例,比较引产与临产前剖宫产的母婴结局。引产组母体复合发病率低于剖宫产组,新生儿发病率两组无显著差异;引产组阴道分娩率53%,引产中位时长13.9小时。

要点

  • 因妊娠期高血压疾病<33周分娩者中,引产与临产前剖宫产相比母体复合发病率显著降低(校正OR 0.44)。
  • 新生儿复合发病率引产组与剖宫产组无显著差异(校正OR 0.71,95%CI 0.48-1.06)。
  • 引产组阴道分娩率53%,引产中位时长13.9小时;≥29周者阴道分娩率高于<29周者。

核心结论

  • 因妊娠期高血压疾病<330周分娩的患者中,引产与临产前剖宫产相比与母体发病率显著降低相关,但与新生儿发病率无显著相关。
  • 引产患者中超过半数经阴道分娩,引产中位时长为13.9小时。

研究设计与样本

  • 观察性研究的二次分析,纳入2008至2011年美国25家医院115502例患者。
  • 纳入因妊娠期高血压疾病(妊娠期高血压或子痫前期)于230至<330周分娩者,排除已知胎儿畸形、多胎妊娠、胎位异常或胎死宫内、以及存在分娩禁忌证者。
  • 共471例符合标准,其中271例(58%)行引产,200例(42%)行临产前剖宫产。

主要发现

  • 母体复合发病率引产组为10.2%,剖宫产组为21.1%(未校正OR 0.42,95%CI 0.25-0.72;校正OR 0.44,95%CI 0.26-0.76)。
  • 新生儿复合发病率引产组为51.9%,剖宫产组为63.8%(未校正OR 0.61,95%CI 0.42-0.89;校正OR 0.71,95%CI 0.48-1.06)。
  • 引产组阴道分娩率为53%(95%CI 46.8-58.7),分娩中位时长为13.9小时(四分位距8.7-22.2)。
  • 240-286周组阴道分娩率为39.9%,290-<330周组为56.3%(P=.01)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hypertensive disorders of pregnancy are the leading cause of indicated preterm birth; however, the optimal delivery approach for pregnancies complicated by preterm hypertensive disorders of pregnancy remains uncertain. OBJECTIVE: This study aimed to compare maternal and neonatal morbidity in patients with hypertensive disorders of pregnancy who either went induction of labor or prelabor cesarean delivery at <33 weeks' gestation. In addition, we aimed to quantify the length of induction of labor and rate of vaginal delivery in those who underwent induction of labor. STUDY DESIGN: This is a secondary analysis of an observational study which included 115,502 patients in 25 hospitals in the United States from 2008 to 2011. Patients were included in the secondary analysis if they were delivered for pregnancy associated hypertension (gestational hypertension or preeclampsia) between 230 and <330 weeks' gestation; and were excluded for known fetal anomalies, multiple gestation, fetal malpresentation or demise, or a contraindication to labor. Maternal and neonatal adverse composite outcomes were evaluated by intended mode of delivery. Secondary outcomes were duration of labor induction and rate of cesarean delivery in those who underwent labor induction. RESULTS: A total of 471 patients met inclusion criteria, of whom 271 (58%) underwent induction of labor and 200 (42%) underwent prelabor cesarean delivery. Composite maternal morbidity was 10.2% in the induction group and 21.1% in the cesarean delivery group (unadjusted odds ratio, 0.42 [0.25-0.72]; adjusted odds ratio, 0.44 [0.26-0.76]). Neonatal morbidity in the induction group vs the cesarean delivery was 51.9% and 63.8 %, respectively (unadjusted odds ratio, 0.61 [0.42-0.89]; adjusted odds ratio, 0.71 [0.48-1.06]). The frequency of vaginal delivery in the induction group was 53% (95% confidence interval, 46.8-58.7) and the median duration of labor was 13.9 hours (interquartile range, 8.7-22.2). The frequency of vaginal birth was higher in patients at or beyond 29 weeks (39.9% at 240-286 weeks, 56.3% at 290-<330 weeks; P=.01). CONCLUSION: Among patients delivered for hypertensive disorders of pregnancy <330 weeks, labor induction compared with prelabor cesarean delivery is associated with significantly lower odds of maternal but not neonatal morbidity. More than half of patients induced delivered vaginally, with a median duration of labor induction of 13.9 hours.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Bushman ET, Grobman WA, Bailit JL, et al. Outcomes of induction vs prelabor cesarean delivery at <33 weeks for hypertensive disorders of pregnancy. Am J Obstet Gynecol MFM. 2023. PMID: 37244639. doi:10.1016/j.ajogmf.2023.101032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。